S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction
Publication
, Conference
Pleger, ST; Most, P; Heidt, B; Völkers, M; Weichenhan, D; Koch, WJ; Katus, HA; Remppis, A
Published in: EUROPEAN HEART JOURNAL
2004
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
ISSN
0195-668X
Publication Date
2004
Volume
25
Start / End Page
546 / 546
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Pleger, S. T., Most, P., Heidt, B., Völkers, M., Weichenhan, D., Koch, W. J., … Remppis, A. (2004). S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction. In EUROPEAN HEART JOURNAL (Vol. 25, pp. 546–546).
Pleger, S. T., P. Most, B. Heidt, M. Völkers, D. Weichenhan, W. J. Koch, H. A. Katus, and A. Remppis. “S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction.” In EUROPEAN HEART JOURNAL, 25:546–546, 2004.
Pleger ST, Most P, Heidt B, Völkers M, Weichenhan D, Koch WJ, et al. S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction. In: EUROPEAN HEART JOURNAL. 2004. p. 546–546.
Pleger, S. T., et al. “S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction.” EUROPEAN HEART JOURNAL, vol. 25, 2004, pp. 546–546.
Pleger ST, Most P, Heidt B, Völkers M, Weichenhan D, Koch WJ, Katus HA, Remppis A. S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction. EUROPEAN HEART JOURNAL. 2004. p. 546–546.
Published In
EUROPEAN HEART JOURNAL
ISSN
0195-668X
Publication Date
2004
Volume
25
Start / End Page
546 / 546
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology